These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27677313)

  • 1. Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer.
    Pelissier A; Roulot A; Guéry B; Bonneau C; Bellet D; Rouzier R
    J Ovarian Res; 2016 Sep; 9(1):61. PubMed ID: 27677313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
    Angioli R; Plotti F; Capriglione S; Aloisi A; Montera R; Luvero D; Miranda A; Cafà EV; Damiani P; Benedetti-Panici P
    Gynecol Oncol; 2013 Mar; 128(3):579-83. PubMed ID: 23220563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.
    Chudecka-Głaz AM; Cymbaluk-Płoska AA; Menkiszak JL; Sompolska-Rzechuła AM; Tołoczko-Grabarek AI; Rzepka-Górska IA
    J Ovarian Res; 2014; 7():62. PubMed ID: 25018782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study.
    Feng LY; Liao SB; Li L
    J Ovarian Res; 2020 Feb; 13(1):17. PubMed ID: 32050995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
    Pelissier A; Bonneau C; Chéreau E; de La Motte Rouge T; Fourchotte V; Daraï E; Rouzier R
    Gynecol Oncol; 2014 Dec; 135(3):542-6. PubMed ID: 25223808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma.
    Tang Z; Chang X; Ye X; Li Y; Cheng H; Cui H
    Chin J Cancer Res; 2015 Jun; 27(3):309-17. PubMed ID: 26157328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer.
    Rong Y; Li L
    J Ovarian Res; 2021 Jan; 14(1):2. PubMed ID: 33397458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity.
    Pelissier A; Bonneau C; Chéreau E; DE LA Motte Rouge T; Fourchotte V; Daraï E; Rouzier R
    Anticancer Res; 2016 Apr; 36(4):1865-71. PubMed ID: 27069172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of human epididymis protein 4 in predicting optimal cytoreductive therapy in patients with advanced ovarian cancer.
    Paunovic V; Protrka Z; Ardalic D; Paunovic T
    J BUON; 2017; 22(1):29-33. PubMed ID: 28365932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?
    Angioli R; Capriglione S; Aloisi A; Guzzo F; Luvero D; Miranda A; Damiani P; Montera R; Terranova C; Plotti F
    Tumour Biol; 2014 Jul; 35(7):7009-15. PubMed ID: 24748235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer.
    Kotowicz BU; Fuksiewicz M; Bidzinski M; Berezowska A; Sobiczewski P; Kowalska MM
    Ginekol Pol; 2022; 93(11):910-915. PubMed ID: 36621970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study.
    Huang J; Du D; Chen H; Luo D; Wang Q; Li C; Li Y; Yu Y
    Front Oncol; 2024; 14():1399502. PubMed ID: 38863620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer.
    Yang Z; Luo Z; Zhao B; Zhang W; Zhang J; Li Z; Li L
    Oncol Lett; 2013 Jul; 6(1):28-34. PubMed ID: 23946773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
    Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HE4 and ROMA index in Czech postmenopausal women.
    Novotny Z; Presl J; Kucera R; Topolcan O; Vrzalova J; Fuchsova R; Betincova L; Rokyta Z
    Anticancer Res; 2012 Sep; 32(9):4137-40. PubMed ID: 22993374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients.
    Saffarieh E; Nassiri S; Mirmohammadkhani M
    Eur J Transl Myol; 2022 Aug; 32(3):. PubMed ID: 35916763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma.
    Zeng J; Yin J; Song X; Jin Y; Li Y; Pan L
    J Cancer; 2016; 7(15):2327-2332. PubMed ID: 27994671
    [No Abstract]   [Full Text] [Related]  

  • 20. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.